Comparison

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

 

Click on the organs and learn more about cancer types

´

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

2719 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Tecotabart Biosimilar -­ Research Grade Hu FA CHO cells ICH5905-25mg

IchorBio
25 mg Login
Compare
Tecotabart Biosimilar -­ Research Grade Hu FA CHO cells ICH5905-50mg

IchorBio
50 mg Login
Compare
Tecotabart Biosimilar -­ Research Grade Hu FA CHO cells ICH5905-5mg

IchorBio
5 mg Login
Compare
Teneliximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5915-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Teneliximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5915-1mg

IchorBio
1 mg Login
Compare
Teneliximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5915-25mg

IchorBio
25 mg Login
Compare
Teneliximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5915-50mg

IchorBio
50 mg Login
Compare
Teneliximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5915-5mg

IchorBio
5 mg Login
Compare
Timigutuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5925-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Timigutuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5925-1mg

IchorBio
1 mg Login
Compare
Timigutuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5925-25mg

IchorBio
25 mg Login
Compare
Timigutuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5925-50mg

IchorBio
50 mg Login
Compare
Timigutuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5925-5mg

IchorBio
5 mg Login
Compare
Imgatuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5600-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Imgatuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5600-1mg

IchorBio
1 mg Login
Compare
Imgatuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5600-25mg

IchorBio
25 mg Login
Compare
Imgatuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5600-50mg

IchorBio
50 mg Login
Compare
Imgatuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5600-5mg

IchorBio
5 mg Login
Compare
Indusatumab Vedotin Biosimilar -­ Research Grade Hu FA CHO cells ICH5604V-0.1mg

IchorBio
0.1 mg Login
Compare
Indusatumab Vedotin Biosimilar -­ Research Grade Hu FA CHO cells ICH5604V-1mg

IchorBio
1 mg Login
Compare
Inolimomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5605-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Inolimomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5605-1mg

IchorBio
1 mg Login
Compare
Inolimomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5605-25mg

IchorBio
25 mg Login
Compare
Inolimomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5605-50mg

IchorBio
50 mg Login
Compare
Inolimomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5605-5mg

IchorBio
5 mg Login
Compare
Name Price
Tecotabart Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Tecotabart Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Tecotabart Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Teneliximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Teneliximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Teneliximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Teneliximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Teneliximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Timigutuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Timigutuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Timigutuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Timigutuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Timigutuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Imgatuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Imgatuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Imgatuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Imgatuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Imgatuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Indusatumab Vedotin Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 0.1 mg
Available
Indusatumab Vedotin Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Inolimomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Inolimomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Inolimomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Inolimomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Inolimomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available

2719 Item(s)

per page